<?xml version="1.0" encoding="UTF-8"?>
<p>Natural mumps infection has been considered to give life-long immunity. However, the duration of vaccine-induced immunity has not been well documented, but detectable specific mumps virus-neutralizing antibodies correlate with resistance to clinical infection [
 <xref rid="B90-ijerph-17-01686" ref-type="bibr">90</xref>]. It has been found that the efficacy of the mumps vaccine containing the Jeryl Lynn strain was 95–96% [
 <xref rid="B90-ijerph-17-01686" ref-type="bibr">90</xref>]. The effectiveness of two doses of MMR immunization is not as high as expected, and outbreaks have been reported in countries with high vaccine coverage [
 <xref rid="B91-ijerph-17-01686" ref-type="bibr">91</xref>,
 <xref rid="B92-ijerph-17-01686" ref-type="bibr">92</xref>,
 <xref rid="B93-ijerph-17-01686" ref-type="bibr">93</xref>]. It was reported that the estimated vaccine effectiveness for one-dose MMR vaccination was 85.4% (95% CI: 67.3–93.4%), and that for two-dose MMR vaccination was 88.5% (95% CI: 78.1–93.9%) in a study in Spain [
 <xref rid="B94-ijerph-17-01686" ref-type="bibr">94</xref>].
</p>
